Oberholzer-Gee, Felix. "Amgen Inc.'s Epogen-Commercializing the First Biotech Blockbuster Drug (TN)." Harvard Business School Teaching Note 707-542, March 2007.
For the best part of a decade, Amgen's Epogen has been the best-selling biotech drug. This situation has now changed with the appearance of two arthritis drugs—Centocor's Remicade and Immunex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results